Centre François-Baclesse, BP 45026, 14076 Caen cedex 5, France.
Centre François-Baclesse, BP 45026, 14076 Caen cedex 5, France.
Cancer Radiother. 2022 Feb-Apr;26(1-2):388-396. doi: 10.1016/j.canrad.2021.11.007. Epub 2021 Dec 23.
Radiotherapy for Hodgkin lymphomas has evolved a lot over time, but still plays an important role, almost always in addition to chemotherapy, for the management of the early stages. The major objective is to preserve the quality of life of patients who will be cured from this disease in the vast majority of cases. Also, the personalization of the indications for the purpose of de-escalating toxicity is very refined and is essentially based on the pre- and pertherapeutic assessment by FDG-PET. The indications for radiotherapy are more limited for non-Hodgkin lymphomas, but the same principles are found, regardless of the histological type. We present the update of the recommendations of the French society of oncological radiotherapy for radiotherapy of lymphomas, which remains a very evolving field in terms of therapeutic strategy and evaluation.
放射治疗霍奇金淋巴瘤已经有了很大的发展，但仍然起着重要的作用，几乎总是在化疗之外，用于早期阶段的治疗。主要目标是为绝大多数可以治愈这种疾病的患者保留生活质量。此外，为了降低毒性而进行的个体化治疗的适应证非常精细，主要基于 FDG-PET 的治疗前和治疗后评估。放射治疗的适应证对于非霍奇金淋巴瘤更有限，但无论组织学类型如何，都可以找到相同的原则。我们介绍了法国肿瘤放射治疗学会对淋巴瘤放射治疗的建议更新，这在治疗策略和评估方面仍然是一个非常活跃的领域。
